Kevin Lind (L) and Amit Munshi
October 28, 2020 09:18 AM EDT
Financing
Startups

Are­na's Amit Mun­shi spins out his neu­ro sub in­to a biotech start­up, with $56M for the bap­tism

John Carroll

Editor & Founder

Back in Jan­u­ary, Are­na Phar­ma $AR­NA CEO Amit Mun­shi turned up at JP Mor­gan with am­bi­tious plans for 2020. Near the …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Pfiz­er look­ing to sell hos­pi­tal drugs unit — re­ports

As­traZeneca CEO reaf­firms com­mit­ment to Chi­na fol­low­ing ex­ec­u­tive's de­ten­tion

'Ex­per­tise is a re­al thing': FDA com­mis­sion­er warns of po­lit­i­cal risk to agency

Mer­ck, As­traZeneca tout Phase 3 win for can­cer-turned-rare dis­ease drug

No­var­tis pays $150M up­front to Schrödinger in new drug deal, ramps up soft­ware use

sponsored

What Will It Take to Re­verse Fi­bro­sis in Pa­tients with Ad­vanced MASH?

A service from the Financial Times